Titles

Professor of Psychiatry

Director, Kahlert Institute for Addiction Medicine

School Affiliation

School of Medicine

Specialties

• Addiction Medicine
• Opioid Use Disorder

About

kelly.dunn@som.umaryland.edu

Kelly Dunn, PhD, MBA, is one of the nation’s leading researchers on opioid use disorder. She is a Professor of Psychiatry and Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine. Dr. Dunn has been the Principal Investigator on projects totaling more than $21 million in awards from the National Institutes of Health. She has authored more than 130 peer-reviewed publications in the area of substance use and opioid use disorder. She has also managed trials focused on treatments for cigarette smoking and alcohol use disorder and has conducted several basic science human laboratory examinations of drug effects, which is complemented by a body of work focused on epidemiological and machine-learning analyses of publicly available datasets. Dr. Dunn has held multiple leadership roles in the substance use field, including serving as President for the American Psychological Association’s Society for Psychopharmacology and Substance Use and the College on the Problems of Drug Dependence (CPDD) as well as Co-Editor of the Journal of Addiction Medicine and Editor-in-Chief of the journal Experimental and Clinical Psychopharmacology.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged:

This information was last updated December 18, 2024.